Department of Medical Epidemiology and Biostatistics, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Sweden.
Division of Biostatistics (FT), Department of Preventive Medicine, and Division of Nephrology, Department of Internal Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.
J Ren Nutr. 2018 Nov;28(6):380-392. doi: 10.1053/j.jrn.2018.08.006.
To better define the prevalence of protein-energy wasting (PEW) in kidney disease is poorly defined.
We performed a meta-analysis of PEW prevalence from contemporary studies including more than 50 subjects with kidney disease, published during 2000-2014 and reporting on PEW prevalence by subjective global assessment or malnutrition-inflammation score. Data were reviewed throughout different strata: (1) acute kidney injury (AKI), (2) pediatric chronic kidney disease (CKD), (3) nondialyzed CKD 3-5, (4) maintenance dialysis, and (5) subjects undergoing kidney transplantation (Tx). Sample size, period of publication, reporting quality, methods, dialysis technique, country, geographical region, and gross national income were a priori considered factors influencing between-study variability.
Two studies including 189 AKI patients reported a PEW prevalence of 60% and 82%. Five studies including 1776 patients with CKD stages 3-5 reported PEW prevalence ranging from 11% to 54%. Finally, 90 studies from 34 countries including 16,434 patients on maintenance dialysis were identified. The 25th-75th percentiles range in PEW prevalence among dialysis studies was 28-54%. Large variation in PEW prevalence across studies remained even when accounting for moderators. Mixed-effects meta-regression identified geographical region as the only significant moderator explaining 23% of the observed data heterogeneity. Finally, two studies including 1067 Tx patients reported a PEW prevalence of 28% and 52%, and no studies recruiting pediatric CKD patients were identified.
By providing evidence-based ranges of PEW prevalence, we conclude that PEW is a common phenomenon across the spectrum of AKI and CKD. This, together with the well-documented impact of PEW on patient outcomes, justifies the need for increased medical attention.
更好地定义肾脏疾病中的蛋白质-能量消耗(PEW)的流行情况定义较差。
我们进行了一项荟萃分析,纳入了 2000 年至 2014 年间发表的超过 50 例肾脏疾病患者的研究,这些研究通过主观整体评估或营养不良-炎症评分报告 PEW 流行率。通过不同分层审查数据:(1)急性肾损伤(AKI),(2)儿科慢性肾脏病(CKD),(3)非透析 CKD 3-5 期,(4)维持性透析和(5)接受肾移植(Tx)的患者。样本量、发表期限、报告质量、方法、透析技术、国家、地理位置和国民总收入被认为是影响研究间变异性的因素。
两项纳入 189 例 AKI 患者的研究报告 PEW 流行率为 60%和 82%。五项纳入 1776 例 CKD 3-5 期患者的研究报告 PEW 流行率为 11%至 54%。最后,从 34 个国家确定了 90 项研究,共纳入 16434 例维持性透析患者。透析研究中 PEW 流行率的 25 至 75 百分位范围为 28%至 54%。即使考虑到调节因素,研究之间 PEW 流行率的差异仍然很大。混合效应荟萃回归确定地理位置是唯一显著的调节因素,解释了观察到的 23%数据异质性。最后,两项纳入 1067 例 Tx 患者的研究报告 PEW 流行率为 28%和 52%,没有发现招募儿科 CKD 患者的研究。
通过提供基于证据的 PEW 流行率范围,我们得出结论,PEW 是 AKI 和 CKD 谱中常见的现象。鉴于 PEW 对患者结局的影响有据可查,这表明需要加强对 PEW 的关注。